Skip to content

Effect of Lithium Carbonate on Postoperative Sleep and Cognitive Function in Patients Undergoing Heart Valve Surgery With Cardiopulmonary Bypass

Effect of Lithium Carbonate on Postoperative Sleep and Cognitive Function in Patients Undergoing Heart Valve Surgery With Cardiopulmonary Bypass

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05593627
Enrollment
62
Registered
2022-10-25
Start date
2023-07-01
Completion date
2026-07-30
Last updated
2023-07-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart Valve Surgery

Keywords

lithium carbonate, polysomnography

Brief summary

It has been proved that lithium carbonate can prolong slow wave sleep with few or no side-effects. The aim of the present study is to evaluate postoperative sleep quality of patients undergoing heart valve surgery with cardiopulmonary bypass taken 250mg lithium carbonate after surgery.

Detailed description

This study is a prospective, randomized, controlled (randomized, parallel group, concealed allocation), double-blinded trial. All patients undergoing heart valve surgery with cardiopulmonary bypass will be randomized 1:1 to the treatment intervention with lithium carbonate 250mg (Baoqing, Hunan, China) or calcium carbonate 500mg (Reneed, Beijing, China) after surgery. The objective of the trial is to evaluate the lithium carbonate 250mg on the postoperative night sleep quality. Duration of sleep was collected with polysomnography on second postoperative night. (from 20:00pm to 06:00. Mini-Mental State Examination (MMSE) score was performed on the seventh postoperative day

Interventions

DRUGLithium Carbonate 250 MG Oral Tablet

Patients undergoing heart valve surgery withcardiopulmonary bypass will take 250mg lithium carbonate

Patients undergoing heart valve surgery withcardiopulmonary bypass will take 500mg calcium carbonate

Sponsors

China Medical University, China
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Ethnic Chinese; * Age, 18 to 65 years old; * Patients undergoing heart valve surgery with cardiopulmonary bypass

Exclusion criteria

* Preoperative Pittsburgh Sleep Quality Index global scores higher than 6 * Cognitive difficulties * Partial or complete gastrectomy * Previous esophageal surgery * Previous treated by radiotherapy or surgery * Inability to conform to the study's requirements * Body mass index exceeding 30 kg/m2 * Deprivation of a right to decide by an administrative or juridical entity * Ongoing participation or participation in another study \<1 month ago * Recent (\< 3 months prior) use of antibiotics, probiotics, prebiotics, symbiotics, hormonal medication, laxatives, proton pump inhibitors, insulin sensitizers or traditional Chinese medicine

Design outcomes

Primary

MeasureTime frameDescription
sleep qualityon the second postoperative night from 20:00 to 6:00Duration of sleep was collected with polysomnography on second postoperative night. (from 20:00pm to 06:00am)

Secondary

MeasureTime frameDescription
serum metabolitesfrom baseline to postoperative 72 hoursThis study will characterize the serum metabolites of patients before and after heart valve surgery

Other

MeasureTime frameDescription
Cognitive functionon the seventh postoperative dayMini-Mental State Examination (MMSE) score was performed

Countries

China

Contacts

Primary ContactWenfei Tan
winfieldtan@hotmail.com024-83283100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026